Published in Gene Therapy Weekly, March 18th, 2010
"AAV serotypes 1-6 and 8 and a lentiviral vector (LV) were used, all encoding green fluorescent protein (GFP) under control of the cytomegalovirus (CMV) promoter. AAV vectors were titer matched at 5 x 10(11) genomic copies (GC)/ml and 1 mu l was injected into the red nucleus. The proportion of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly